| Literature DB >> 31497509 |
Hadi Tabarraei1,2, Jalal Hassan2, Mohammad Reza Parvizi1, Hannaneh Golshahi3, Hossain Keshavarz-Tarikhi4.
Abstract
The aim of the present study was to evaluate the acute toxicity as lethal dose 50% (LD50) and sub-acute toxicity of the black caraway Bunium persicum (Bioss) seed essential oil in male Wistar rats. The compounds of B. persicum were identified by GC/MS and amount of each compound was evaluated. 21 different compounds were determined in the essential oil and the main components were: carvone, p-cymene, gamma-terpinene, p-cymene-8-ol, limonene, isoterpinolene, and 2-beta pinene. For acute toxicity evaluation, the animals were randomly divided into nine group (n = 6) and received 500, 1000, 1500, 2000, 2500, 3000, 3500 and 4000 mg/kg seed essential oil, respectively and the LD50 value for black caraway seed essential oil was obtained above 4000 mg/kg body weight. According to data, treatment with the black caraway seed essential oil sub-acute toxicity study attenuated histopathological changes in lung, liver, kidney, testes and spleen tissues and the results of this study show that the black caraway essential oil can not affect the immune and blood system, important enzymes and vital organs of the body..Entities:
Keywords: Acute toxicity; Black caraway (Bunium persicum); Essential oil; Rat; Sub-acute toxicity
Year: 2019 PMID: 31497509 PMCID: PMC6719284 DOI: 10.1016/j.toxrep.2019.08.010
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Effect of Bunium persicum Bioss essential oil on hematological parameters after 14 days' treatment.
| The black Caraway essential oil (mg/kg body weight) | ||||
|---|---|---|---|---|
| Parameters | 0 | 250 | 500 | 1000 |
| Total RBC (1012/L) | 8.5 ± 0.1 a | 8.9 ± 0.1ab | 8.0 ± 0.2 a | 7.6 ± 0.8ab |
| HGB (g/dL) | 14.9 ± 0.5a | 14.6 ± 0.4 a | 17.1 ± 0.5 a | 14.9 ± 2.0 a |
| MPV (%) | 7.8 ± 0.4 ab | 6.6 ± 0.2 ab | 6.4 ± 0.8 ab | 4.5 ± 0.3 ab |
| RDW (%) | 12.9 ± 0.6 a | 12.7 ± 1.6 a | 14.3 ± 0.9 a | 13.0 ± 2.5 a |
| MCV (fl) | 46.9 ± 1.7 ab | 57.4 ± 0.7 ab | 50.6 ± 2.1 ab | 55.5 ± 2.7 ab |
| MCH (pg) | 22.8 ± 3.1 a | 22.8 ± 3.2 a | 26.9 ± 7.0 a | 25.9 ± 6.4 a |
| MCHC (%) | 45.9 ± 1.7 a | 42.0 ± 1.6 a | 43.7 ± 2.1 a | 46.5 ± 8.4 a |
| WBC (109/L) | 8.1 ± 0.3 a | 8.2 ± 1.0 a | 9.5 ± 1.1 a | 9.4 ± 3.1 a |
| HCT (%) | 41.9 ± 1.1 a | 40.0 ± 2.0 a | 43.0 ± 1.2 a | 37.4 ± 3.5 a. |
| PLT(109/L) | 818.4 ± 61.2 a | 786.5 ± 72.6 a | 744.7 ± 100.8 a | 525.0 ± 213.9 a |
RBC, red blood cell count; WBC, white blood cell count; RDW, Red cell distribution width; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MPV, Mean platelet volume; HGB, hemoglobin; HCT, hematocrit; fL, femtolitre; pg, pictogram.
*Each value represents the mean ± SD.
aNot significant; when compared with control P < 0.05).
In the same row, mean values with different superscript letters differ significantly (P<0.05).
Effect of Bunium persicum Bioss essential oil on biochemical parameters after 14 days' treatment.
| The black Caraway essential oil (mg/kg body weight) | ||||
|---|---|---|---|---|
| Parameters | 0 | 250 | 500 | 1000 |
| Total Protein (g/dL) | 7.1 ± 0.1 a | 6.9 ± 0.2 a | 6.9 ± 0.3 a | 6.6 ± 0.4 a |
| Creatinine (mg/dL) | 0.9 ± 0.1 a | 0.9 ± 0.1 a | 1.0 ± 0.2 a | 1.4 ± 0.2 a |
| Urea (mg/dL) | 2.0 ± 0.2 a | 2.9 ± 0.4 a | 3.6 ± 0.6 a | 4.1 ± 1.2 a |
| ALT (IU/L) | 40.4 ± 1.0 a | 38.7 ± 1.7 a | 41.4 ± 5.0 a | 46.9 ± 6.4 a |
| ALP (IU/L) | 98.6 ± 24.2 a | 146.2 ± 18.2 a | 162.2 ± 28.7 a | 177.0 ± 48.1 a |
| AST (IU/L) | 77.9 ± 18.6a | 88.4 ± 15.1 a | 93.0 ± 32.5 a | 132.5 ± 51.1 a |
| CPK (IU/L) | 342. ± 28.0 a | 293.0 ± 22.6 a | 337.7 ± 29.3 a | 355.0 ± 65.0 a |
| Albumin (g/dL) | 3.8 ± 0.1 a | 3.8 ± 0.2 a | 3.9 ± 0.1 a | 3.5 ± 0.2 a |
| BUN (mg/dL) | 27.0 ± 3.3 ab | 31.3 ± 4.7 ab | 38.1 ± 4.2 ab | 47.0 ± 4.4 ab |
ALT, alanine transaminase; AST, aspartate transaminase; ALP: Alkaline phosphatase, CPK: Creatinine phosphokinase; BUN: blood urea nitrogen.
*Each value represents the mean ± SD.
aNot significant; when compared with control P < 0.05).
In the same row, mean values with different superscript letters differ significantly (P<0.05).
Fig. 1Group I (control): Note to normal structure of liver (A), kidney (B), spleen (C), lung (D), testis(E), and heart (F) tissue (H & E; A-E: 50 μm and F: 20 μm).
Fig. 2Group II (250 mg/kg body weight): Diffuse vacuolar degeneration (circle), atrophy of hepatocytes (arrow), and dilated sinusoidal space (star) (A), diffuse degenerative change in cells of renal tubules (arrow) (B), Mild depletion in the lymphocyte population of white pulp (rectangle) (C), testicular tubular atrophy (rectangle) and degenerative changes (arrow) (D), mild interstitial inflammation in lung tissue (circle) (E), and fragmentation in the cardiac muscle fibers (arrow) (F) (H & E; A–C, F: 20 μm and D-E: 50 μm).
Fig. 3Group II (1000 mg/kg body weight): moderate to severe diffuse vacuolar degeneration (arrow) and vascular congestion (circle) (A), moderate degenerative changes (arrow) and atrophic glomeruli (circle) (B), increase in the number of inflammatory cell components (arrow) and depletion of white pulp (circle) (C), degenerative and destructive sings of seminiferous tubules (arrow) (D), moderate infiltration of mononuclear inflammatory cells in the interstitium (E), and note to some foci of disrupted cardiac muscle fibers (arrow) (F) (H & E; A-F: 50 μm).